Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120

被引:178
作者
Cormier, EG
Persuh, M
Thompson, DAD
Lin, SW
Sakmar, TP
Olson, WC
Dragic, T
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[2] Publ Hlth Res Inst City New York Inc, New York, NY 10016 USA
[3] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA
[4] Progen Pharmaceut Inc, Tarrytown, NY 10591 USA
关键词
D O I
10.1073/pnas.97.11.5762
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The HIV-1 envelope glycoprotein gp120 interacts consecutively with CD4 and the CCR5 coreceptor to mediate the entry of certain HIV-1 strains into target cells. Acidic residues and sulfotyrosines in the amino-terminal domain (Nt) of CCR5 are crucial for viral fusion and entry. We tested the binding of a panel of CCR5 Nt peptides to different soluble gp120/CD4 complexes and anti-CCR5 mAbs, The tyrosine residues in the peptides were sulfated, phosphorylated, or unmodified. None of the gp120/CD4 complexes associated with peptides containing unmodified or phosphorylated tyrosines, The gp120/CD4 complexes containing envelope glycoproteins from isolates that use CCR5 as a coreceptor associated with Nt peptides containing sulfotyrosines but not with peptides containing sulfotyrosines in scrambled Nt sequences. Finally, only peptides containing sulfotyrosines inhibited the entry of an R5 isolate. Our data show that proper posttranslational modification of the CCR5 Nt is required for gp120 binding and viral entry. More importantly, the Nt domain determines the specificity of the interaction between CCR5 and gp120s from isolates that use this coreceptor.
引用
收藏
页码:5762 / 5767
页数:6
相关论文
共 41 条
[1]   EXPRESSION AND CHARACTERIZATION OF CD4-IGG(2), A NOVEL HETEROTETRAMER THAT NEUTRALIZES PRIMARY HIV TYPE-1 ISOLATES [J].
ALLAWAY, GP ;
DAVISBRUNO, KL ;
BEAUDRY, GA ;
GARCIA, EB ;
WONG, EL ;
RYDER, AM ;
HASEL, KW ;
GAUDUIN, MC ;
KOUP, RA ;
MCDOUGAL, JS ;
MADDON, PJ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (05) :533-539
[2]   Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines [J].
Atchison, RE ;
Gosling, J ;
Monteclaro, FS ;
Franci, C ;
Digilio, L ;
Charo, IF ;
Goldsmith, MA .
SCIENCE, 1996, 274 (5294) :1924-1926
[3]   MECHANISM OF INHIBITORY EFFECT OF DEXTRAN SULFATE AND HEPARIN ON REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS INVITRO [J].
BABA, M ;
PAUWELS, R ;
BALZARINI, J ;
ARNOUT, J ;
DESMYTER, J ;
DECLERCQ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) :6132-6136
[4]   TYROSINE SULFATION IS A TRANS-GOLGI-SPECIFIC PROTEIN MODIFICATION [J].
BAEUERLE, PA ;
HUTTNER, WB .
JOURNAL OF CELL BIOLOGY, 1987, 105 (06) :2655-2664
[5]   CHLORATE - A POTENT INHIBITOR OF PROTEIN SULFATION IN INTACT-CELLS [J].
BAEUERLE, PA ;
HUTTNER, WB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 141 (02) :870-877
[6]   Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[7]   HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor [J].
Bieniasz, PD ;
Fridell, RA ;
Aramori, I ;
Ferguson, SSG ;
Caron, MG ;
Cullen, BR .
EMBO JOURNAL, 1997, 16 (10) :2599-2609
[8]   HIV entry and its inhibition [J].
Chan, DC ;
Kim, PS .
CELL, 1998, 93 (05) :681-684
[9]   A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor [J].
Doranz, BJ ;
GrovitFerbas, K ;
Sharron, MP ;
Mao, SH ;
Goetz, MB ;
Daar, ES ;
Doms, RW ;
OBrien, WA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (08) :1395-1400
[10]   Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1 [J].
Doranz, BJ ;
Lu, ZH ;
Rucker, J ;
Zhang, TY ;
Sharron, M ;
Cen, YH ;
Wang, ZX ;
Guo, HH ;
Du, JG ;
Accaviti, MA ;
Doms, RW ;
Peiper, SC .
JOURNAL OF VIROLOGY, 1997, 71 (09) :6305-6314